First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat
Veröffentlicht: 19.03.2026 um 22:06 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat-302711084.html
en | boerse | 68902455 |
